{"version":"1.0","type":"rich","provider_name":"Buzzsprout","provider_url":"https://www.buzzsprout.com","author_url":"https://www.buzzsprout.com/2467194","width":500,"thumbnail_width":600,"thumbnail_height":600,"title":"15. Targeting Misfolded SOD1 in ALS: A First-in-Class Antibody Shows Promise ","author_name":"BioBiz Buzz","html":"<iframe src=\"https://www.buzzsprout.com/2467194/episodes/18130982-15-targeting-misfolded-sod1-in-als-a-first-in-class-antibody-shows-promise?client_source=oembed&amp;iframe=true\" width=\"100%\" height=\"200\" frameborder=\"0\" scrolling=\"no\" loading=\"lazy\" title=\"BioBiz Buzz, 15. Targeting Misfolded SOD1 in ALS: A First-in-Class Antibody Shows Promise \"></iframe>","height":200,"thumbnail_url":"https://www.buzzsprout.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTU4MjU4NTIxLCJwdXIiOiJibG9iX2lkIn19--f9e9915f7d4059d8c24022ce7d342f9c85feb571/eyJfcmFpbHMiOnsiZGF0YSI6eyJmb3JtYXQiOiJqcGciLCJyZXNpemVfdG9fZmlsbCI6WzYwMCw2MDAseyJjcm9wIjoiY2VudHJlIn1dLCJzYXZlciI6eyJxdWFsaXR5Ijo2MH0sImNvbG91cnNwYWNlIjoic3JnYiJ9LCJwdXIiOiJ2YXJpYXRpb24ifX0=--0b154cb6b88107719b1a277923d35676ba5519cc/15.%20ALS.png"}